Kymab
Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.
4
Funding Rounds
$179.4m
Money raised
Funding
Funding series
Funding Series Analysis
The company Kymab has raised a total of $139.4m in funding over 4 rounds.
Key Insights:
- Kymab , January 2017: $9m
- Kymab Series C round, November 2016: $100m
- Kymab Series A round: $30.4m
- Kymab Series B round May 2014: $40m
Kymab , January 2017
$9m
Kymab Series C round, November 2016
$100m
Kymab Series A round
$30.4m
Kymab Series B round May 2014
$40m
Industries
Kymab is active in the following industries: